Mark Reddish
Operationeel Directeur bij Metrodora Therapeutics, Inc.
Profiel
Mark Reddish is currently working as Vice President-Operation at Metrodora Therapeutics, Inc. He previously worked as Senior Director-Research Immunology at Biomira, Inc. from 1991 to 1998, Vice President-Product Development at ID Biomedical Corp.
from 1998 to 2005, and as an Independent Director at Marker Therapeutics, Inc. from 2014 to 2018.
He completed his undergraduate degree from the University of Massachusetts.
Actieve functies van Mark Reddish
| Bedrijven | Functie | Begin |
|---|---|---|
| Metrodora Therapeutics, Inc. | Operationeel Directeur | - |
Eerdere bekende functies van Mark Reddish
| Bedrijven | Functie | Einde |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Directeur/Bestuurslid | 17-10-2018 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01-01-2005 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Corporate Officer/Principal | 01-01-1998 |
Opleiding van Mark Reddish
| University of Massachusetts | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Metrodora Therapeutics, Inc. | |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Health Services |
